GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Adora1 | decreases activity | EXP | | 6480464 | CTD | Caffeine results in decreased activity of ADORA1 protein | PMID:15708489 | Adora1 | decreases expression | EXP | | 6480464 | CTD | Caffeine results in decreased expression of ADORA1 mRNA | PMID:12153486 | Adora1 | multiple interactions | EXP | | 6480464 | CTD | Caffeine inhibits the reaction [N(6)-cyclopentyladenosine binds to and results in increased activity of ADORA1 protein]; Caffeine promotes the reaction [Phenylisopropyladenosine binds to and results in increased activity of ADORA1 protein] | PMID:10401785 PMID:3003150 | Adora1 | decreases activity | ISO | ADORA1 (Homo sapiens) | 6480464 | CTD | Caffeine results in decreased activity of ADORA1 protein | PMID:23611293 | Adora1 | decreases activity | ISO | Adora1 (Mus musculus) | 6480464 | CTD | Caffeine results in decreased activity of ADORA1 protein | PMID:22164264 | Adora1 | decreases expression | ISO | Adora1 (Mus musculus) | 6480464 | CTD | Caffeine deficiency results in decreased expression of ADORA1 mRNA | PMID:29107002 | Adora1 | increases expression | ISO | Adora1 (Mus musculus) | 6480464 | CTD | Caffeine results in increased expression of ADORA1 protein | PMID:7996441 | Adora1 | multiple interactions | ISO | Adora1 (Mus musculus) | 6480464 | CTD | [8-cyclopentyl-1,3-dimethylxanthine binds to and results in decreased activity of ADORA1 protein] inhibits the reaction [[Caffeine co-treated with [N(6)-cyclopentyladenosine binds to and results in increased activity of ADORA1 protein]] results in decreased susceptibility to Methamphetamine]; [Caffeine co-treated with [N(6)-cyclopentyladenosine binds to and results in increased activity of ADORA1 protein]] results in decreased susceptibility to Methamphetamine; [Caffeine co-treated with Mianserin] results in decreased expression of ADORA1 mRNA; [Citalopram co-treated with Caffeine deficiency] results in increased expression of ADORA1 mRNA; [Citalopram co-treated with Caffeine] results in decreased expression of ADORA1 mRNA; [Fluoxetine co-treated with Caffeine deficiency] results in increased expression of ADORA1 mRNA | PMID:29107002 PMID:29882086 PMID:7996441 | |
Go Back to source page | Continue to Ontology report |